Learning the Language of Histopathology Images reveals Prognostic Subgroups in Invasive Lung Adenocarcinoma Patients

学习组织病理学图像的语言有助于揭示侵袭性肺腺癌患者的预后亚组

阅读:2

Abstract

Recurrence remains a major clinical challenge in surgically resected invasive lung adenocarcinoma, where existing grading and staging systems fail to capture the cellular complexity that underlies tumor aggressiveness. We present PathRosetta, a novel AI model that conceptualizes histopathology as a language, where cells serve as words, spatial neighborhoods form syntactic structures, and tissue architecture composes sentences. By learning this language of histopathology, PathRosetta predicts five-year recurrence directly from hematoxylin-and-eosin (H&E) slides, treating them as documents representing the state of the disease. In a multi-cohort dataset of 289 patients (600 slides), PathRosetta achieved an area under the curve (AUC) of 0.78±0.04 on the internal cohort, significantly outperforming IASLC grading (AUC:0.71), AJCC staging (AUC:0.64), and other state-of-the-art AI models (AUC:0.62-0.67). It yielded a hazard ratio of 9.54 and a concordance index of 0.70, generalized robustly to external TCGA (AUC:0.75) and CPTAC (AUC:0.76) cohorts, and performed consistently across demographic and clinical subgroups. Beyond whole-slide prediction, PathRosetta uncovered prognostic subgroups within individual cell types, revealing that even within benign epithelial, stromal, or other cells, distinct morpho-spatial phenotypes correspond to divergent outcomes. Moreover, because the model explicitly understands what it is looking at, including cell types, cellular neighborhoods, and higher-order tissue morphology, it is inherently interpretable and can articulate the rationale behind its predictions. These findings establish that representing histopathology as a language enables interpretable and generalizable prognostication from routine histology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。